SEC Form 4 · accession 0001144204-19-000516
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron Price
Officer — See Remarks
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 8:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $11.50 | Jan 1, 2019 | A | 50,383 | A | — | Jan 1, 2029 | Common Stock | 50,383 | 50,383 | D |
Explanation of responses
- F1The options vest in four (4) equal annual installments on each anniversary of the date of grant beginning on January 1, 2021.
Remarks
SENIOR VICE PRESIDENT AND HEAD OF COMMERCIAL OPERATIONS, AMERICAS